Groesbeck Investment Management Increased Its Cvs (CVS) Stake; 10 Analysts Are Bullish Randgold Resources Ltd. (ADR) (GOLD) Last Week

June 16, 2017 - By Kurt Siggers

Groesbeck Investment Management Corp increased Cvs Corp (CVS) stake by 95.25% reported in 2016Q4 SEC filing. Groesbeck Investment Management Corp acquired 7,955 shares as Cvs Corp (CVS)’s stock declined 4.23%. The Groesbeck Investment Management Corp holds 16,307 shares with $1.29M value, up from 8,352 last quarter. Cvs Corp now has $76.91 billion valuation. The stock declined 4.91% or $3.93 reaching $76.16 on the news. About 5.15M shares traded. CVS Health Corp (NYSE:CVS) has declined 24.40% since June 16, 2016 and is downtrending. It has underperformed by 41.10% the S&P500.

Among 15 analysts covering Randgold-Resources (NASDAQ:GOLD), 10 have Buy rating, 0 Sell and 5 Hold. Therefore 67% are positive. Randgold-Resources had 31 analyst reports since July 24, 2015 according to SRatingsIntel. The rating was downgraded by RBC Capital Markets to “Sector Perform” on Wednesday, February 24. Morgan Stanley upgraded the stock to “Overweight” rating in Thursday, December 1 report. The stock of Randgold Resources Ltd. (ADR) (NASDAQ:GOLD) has “Buy” rating given on Monday, June 27 by Goldman Sachs. HSBC downgraded Randgold Resources Ltd. (ADR) (NASDAQ:GOLD) on Monday, October 26 to “Hold” rating. The firm has “Outperform” rating given on Friday, July 1 by Macquarie Research. The firm earned “Hold” rating on Friday, September 25 by Jefferies. JP Morgan downgraded the stock to “Neutral” rating in Monday, September 14 report. The company was upgraded on Friday, September 9 by UBS. The stock of Randgold Resources Ltd. (ADR) (NASDAQ:GOLD) has “Neutral” rating given on Monday, April 18 by Citigroup. JP Morgan maintained Randgold Resources Ltd. (ADR) (NASDAQ:GOLD) on Monday, August 15 with “Neutral” rating. See Randgold Resources Ltd. (ADR) (NASDAQ:GOLD) latest ratings:

31/01/2017 Broker: Credit Suisse Old Rating: Outperform New Rating: Neutral Downgrade
13/01/2017 Broker: Berenberg Old Rating: Hold New Rating: Buy Upgrade
19/12/2016 Broker: Deutsche Bank Old Rating: Hold New Rating: Buy Upgrade

About 128,814 shares traded. Randgold Resources Ltd. (ADR) (NASDAQ:GOLD) has risen 7.63% since June 16, 2016 and is uptrending. It has underperformed by 9.07% the S&P500.

Randgold Resources Limited is engaged in gold mining, exploration and related activities. The company has market cap of $8.35 billion. The Company’s activities are focused on West and Central Africa. It has a 33.02 P/E ratio. The Firm operates through the gold mining segment.

Since February 1, 2017, it had 0 insider purchases, and 7 selling transactions for $40.53 million activity. Shares for $7.71 million were sold by Denton David M on Friday, March 10. $1.88M worth of CVS Health Corp (NYSE:CVS) was sold by Brennan Troyen A on Tuesday, March 21. 76,494 shares were sold by MERLO LARRY J, worth $5.99 million. Boratto Eva C also sold $479,908 worth of CVS Health Corp (NYSE:CVS) on Friday, March 17. Roberts Jonathan C sold $4.90M worth of stock. 14,104 shares valued at $1.13M were sold by Sussman Andrew on Monday, March 13.

Investors sentiment decreased to 0.74 in Q4 2016. Its down 0.24, from 0.98 in 2016Q3. It dived, as 135 investors sold CVS shares while 627 reduced holdings. 127 funds opened positions while 440 raised stakes. 830.51 million shares or 0.72% less from 836.58 million shares in 2016Q3 were reported. Fic reported 0.42% of its portfolio in CVS Health Corp (NYSE:CVS). Finance Counselors owns 60,098 shares or 0.25% of their US portfolio. Compass stated it has 3.99% in CVS Health Corp (NYSE:CVS). Ahl Ltd Liability Partnership reported 74,508 shares. Ubs Asset Management Americas Inc invested 0.29% in CVS Health Corp (NYSE:CVS). Us Bancorporation De holds 1.45M shares or 0.41% of its portfolio. Cullen Frost Bankers Inc holds 0.55% or 202,980 shares in its portfolio. Amica Mutual Insurance invested in 65,868 shares. Arrow Financial Corp has 0.62% invested in CVS Health Corp (NYSE:CVS). Pettyjohn Wood White reported 73,338 shares or 2.25% of all its holdings. Dekabank Deutsche Girozentrale stated it has 377,104 shares. Moors & Cabot reported 0.69% stake. Baldwin Investment Mgmt Ltd Co reported 0.43% in CVS Health Corp (NYSE:CVS). Independent Incorporated holds 0.22% or 6,020 shares in its portfolio. Bokf Na reported 0.25% stake.

Among 17 analysts covering CVS Health (NYSE:CVS), 10 have Buy rating, 0 Sell and 7 Hold. Therefore 59% are positive. CVS Health had 27 analyst reports since July 22, 2015 according to SRatingsIntel. The firm has “Outperform” rating given on Monday, November 2 by Oppenheimer. The firm earned “Overweight” rating on Monday, November 2 by JP Morgan. The rating was maintained by Citigroup on Monday, May 9 with “Neutral”. As per Wednesday, July 22, the company rating was maintained by Deutsche Bank. The rating was initiated by Robert W. Baird with “Outperform” on Friday, January 22. On Monday, June 20 the stock rating was downgraded by Morgan Stanley to “Equal-Weight”. As per Thursday, August 20, the company rating was maintained by Deutsche Bank. The rating was downgraded by Atlantic Securities to “Neutral” on Monday, February 6. The company was maintained on Thursday, June 23 by Mizuho. The company was maintained on Thursday, May 12 by Jefferies.